Pfizer beats Street 2Q forecasts despite big drop in profit

NEW YORK (AP) — Higher expenses offset a big jump in sales from an acquisition, as Pfizer Inc.'s second-quarter profit plunged 23 percent. The biggest U.S. drugmaker still beat Wall Street's expectations.